These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation. Song MS; Rauw G; Baker GB; Kar S Eur J Neurosci; 2008 Nov; 28(10):1989-2002. PubMed ID: 19046381 [TBL] [Abstract][Full Text] [Related]
9. Synapse- and subtype-specific modulation of synaptic transmission by nicotinic acetylcholine receptors in the ventrobasal thalamus. Nagumo Y; Takeuchi Y; Imoto K; Miyata M Neurosci Res; 2011 Mar; 69(3):203-13. PubMed ID: 21145925 [TBL] [Abstract][Full Text] [Related]
10. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective. Priestley T; Marshall GR; Hill RG; Kemp JA Br J Pharmacol; 1998 Aug; 124(8):1767-73. PubMed ID: 9756395 [TBL] [Abstract][Full Text] [Related]
11. Galantamine enhancement of long-term potentiation is mediated by calcium/calmodulin-dependent protein kinase II and protein kinase C activation. Moriguchi S; Shioda N; Han F; Yeh JZ; Narahashi T; Fukunaga K Hippocampus; 2009 Sep; 19(9):844-54. PubMed ID: 19253410 [TBL] [Abstract][Full Text] [Related]
13. Potentiation of N-methyl-D-aspartate-induced currents by the nootropic drug nefiracetam in rat cortical neurons. Moriguchi S; Marszalec W; Zhao X; Yeh JZ; Narahashi T J Pharmacol Exp Ther; 2003 Oct; 307(1):160-7. PubMed ID: 12805478 [TBL] [Abstract][Full Text] [Related]
14. Agonist concentration dependency of blocking kinetics but not equilibrium block of N-methyl-D-aspartate receptors by memantine. Gilling KE; Jatzke C; Parsons CG Neuropharmacology; 2007 Sep; 53(3):415-20. PubMed ID: 17632186 [TBL] [Abstract][Full Text] [Related]
15. Bis(7)-tacrine prevents glutamate-induced excitotoxicity more potently than memantine by selectively inhibiting NMDA receptors. Liu YW; Li CY; Luo JL; Li WM; Fu HJ; Lao YZ; Liu LJ; Pang YP; Chang DC; Li ZW; Peoples RW; Ai YX; Han YF Biochem Biophys Res Commun; 2008 May; 369(4):1007-11. PubMed ID: 18328812 [TBL] [Abstract][Full Text] [Related]
16. Effects of memantine and galantamine given separately or in association, on memory and hippocampal neuronal loss after transient global cerebral ischemia in gerbils. Lorrio S; Negredo P; Roda JM; García AG; López MG Brain Res; 2009 Feb; 1254():128-37. PubMed ID: 19103181 [TBL] [Abstract][Full Text] [Related]
17. Co-administration of memantine has no effect on the in vitro or ex vivo determined acetylcholinesterase inhibition of rivastigmine in the rat brain. Enz A; Gentsch C Neuropharmacology; 2004 Sep; 47(3):408-13. PubMed ID: 15275830 [TBL] [Abstract][Full Text] [Related]
18. Nefiracetam and galantamine modulation of excitatory and inhibitory synaptic transmission via stimulation of neuronal nicotinic acetylcholine receptors in rat cortical neurons. Moriguchi S; Zhao X; Marszalec W; Yeh JZ; Fukunaga K; Narahashi T Neuroscience; 2009 May; 160(2):484-91. PubMed ID: 19272425 [TBL] [Abstract][Full Text] [Related]
19. The allosteric potentiation of nicotinic acetylcholine receptors by galantamine is transduced into cellular responses in neurons: Ca2+ signals and neurotransmitter release. Dajas-Bailador FA; Heimala K; Wonnacott S Mol Pharmacol; 2003 Nov; 64(5):1217-26. PubMed ID: 14573772 [TBL] [Abstract][Full Text] [Related]
20. The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence. Danysz W; Parsons CG Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S23-32. PubMed ID: 12973747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]